Status:
COMPLETED
Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules
Lead Sponsor:
Yale University
Collaborating Sponsors:
DePaul University
Hispanic Health Council, Inc.
Conditions:
Hepatitis B
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The investigators seek to provide immunization for individuals who are at high risk of contracting hepatitis B virus (HBV) infection because of their illicit drug use. The investigators will be using ...
Eligibility Criteria
Inclusion
- Demonstrate evidence of recent injection drug use (injection stigmata),
- 18 years of age or older,
- Screened for and found susceptible to HBV
- Able to provide informed consent.
Exclusion
- Evidence of intoxication that prevented provision of informed consent.
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
595 Patients enrolled
Trial Details
Trial ID
NCT01259453
Start Date
May 1 2003
End Date
August 1 2006
Last Update
December 14 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hispanic Health Council
Hartford, Connecticut, United States, 06106
2
DePaul University
Chicago, Illinois, United States, 60614
3
Case Western Reserve Universtiy
Cleveland, Ohio, United States, 44106